DUEXIS®

Drug Information Related Patent
Hold Company
HORIZON
Dosage and Administration
TABLET;ORAL
Specification
26.6MG;800MG
Indication
DUEXIS® is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis and to reduce the risk of upper gastrointestinal ulcers.
API
FAMOTIDINE
IBUPROFEN
API Structure
Drug Patent
Patent NoExpiration Date
80674512026/7/18
83091272026/7/18
83182022026/7/18
84499102026/7/18
85012282026/7/18
80670332026/7/18
API Patent
Patent NoExpiration Date
80674512026/7/18
83091272026/7/18
83182022026/7/18
84499102026/7/18
85012282026/7/18
80670332026/7/18
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top